NHS (Neuberger Berman High Yield Strategies Fund) Moat Score: 2/10 (As of Jul. 14, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NHS Neuberger Berman High Yield Strategies Fund Inc NHS
44 GF Score
Price $6.20
GF Value $7.23
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Neuberger Berman High Yield Strategies Fund Moat Score?

Neuberger Berman High Yield Strategies Fund NHS -0.48% 44 Moat Score is 2 as of Jul. 14, 2026. GuruFocus rates NHS with a GF Score™ of 44/100 and a GF Value™ of $7.23 (Modestly Undervalued). The stock has 6 warning signs investors should review. Among 1,696 Asset Management companies, Neuberger Berman High Yield Strategies Fund ranks better than 80.13% on this metric.

Neuberger Berman High Yield Strategies Fund has the Moat Score of 2, which implies that the company might have No Moat - Very weak/transient advantages.

Neuberger Berman High Yield Strategies Fund has No Moat: Neuberger Berman High Yield Strategies Fund Inc has no discernible moat due to the highly competitive nature of the financial services industry, with no significant cost advantages, brand strength, or regulatory barriers.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Neuberger Berman High Yield Strategies Fund might have No Moat - Very weak/transient advantages.

Neuberger Berman High Yield Strategies Fund  (AMEX:NHS) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Neuberger Berman High Yield Strategies Fund Moat Score Related Terms

NHS vs NRO, TPVG, OPP: Moat Score Comparison

For the Asset Management subindustry, Neuberger Berman High Yield Strategies Fund's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Neuberger Berman High Yield Strategies Fund Moat Score vs Asset Management Industry

For the Asset Management industry and Financial Services sector, Neuberger Berman High Yield Strategies Fund's Moat Score distribution charts can be found below:

* The bar in red indicates where Neuberger Berman High Yield Strategies Fund's Moat Score falls into.


NHS
44GF Score
Neuberger Berman High Yield Strategies Fund Inc NHS
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 2 mean?
Neuberger Berman High Yield Strategies Fund (NHS) has a Moat Score of 2 as of Jul. 14, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, Neuberger Berman High Yield Strategies Fund ranks #337 out of 1696 companies in the Asset Management industry, placing it in the top 19.9%.
Is Neuberger Berman High Yield Strategies Fund's Moat Score too high?
Neuberger Berman High Yield Strategies Fund's current Moat Score is 2. Based on the distribution chart, Neuberger Berman High Yield Strategies Fund ranks #337 out of 1696 companies in the Asset Management industry, which is in the top quartile — a strong position relative to peers. Overall, Neuberger Berman High Yield Strategies Fund has a GF Score™ of 44/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Neuberger Berman High Yield Strategies Fund's Moat Score compare to NRO and TPVG?
According to the Asset Management industry distribution chart, Neuberger Berman High Yield Strategies Fund ranks #337 out of 1696 companies for Moat Score. This places Neuberger Berman High Yield Strategies Fund in the top 20% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for an Asset Management company?
A good Moat Score depends on the Asset Management industry context. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. Neuberger Berman High Yield Strategies Fund's current Moat Score is 2. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Neuberger Berman High Yield Strategies Fund stock overvalued right now?
Based on GuruFocus' analysis, Neuberger Berman High Yield Strategies Fund (NHS) is currently considered Modestly Undervalued. The stock's GF Value™ is $7.23, compared to a current price of $6.20 — trading 14.2% below its estimated fair value. The current Moat Score is 2. Neuberger Berman High Yield Strategies Fund's overall GF Score™ is 44/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For Neuberger Berman High Yield Strategies Fund (NHS), the current Moat Score is 2 as of Jul. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Neuberger Berman High Yield Strategies Fund (NHS) Overvalued in 2026?

Based on GuruFocus' analysis, Neuberger Berman High Yield Strategies Fund stock appears to be undervalued. The current stock price of $6.20 is trading 14.2% below its estimated GF Value™ of $7.23. GuruFocus considers Neuberger Berman High Yield Strategies Fund to be Modestly Undervalued.

Key valuation signals for NHS:

  • Moat Score: 2
  • GF Value™: $7.23 vs. price of $6.20 (14.2% below fair value)
  • GF Score™: 44/100 with 6 warning signs

No single metric tells the full story. See the NHS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Neuberger Berman High Yield Strategies Fund Business Description

Address c/o Neuberger Berman Investment Advisers LLC, 1290 Avenue of the Americas, New York, NY, USA, 10104-0002
Neuberger Berman High Yield Strategies Fund Inc is a diversified, closed-end management investment company. The company invests in high yield debt securities market. The Fund uses leverage to pursue its investment objective. The Fund may invest in a variety of direct debt instruments, including bank loans, notes and other interests in amounts owed to financial institutions by borrowers, such as companies and governments. Corporate loans in which the Fund may invest will consist of direct obligations of borrowers. The Fund may invest in corporate loans at origination as a co-lender or may acquire loans in the secondary market by purchasing participations in, assignments of or novations of corporate loans.
44GF Score

Get the complete analysis for NHS

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$6.20
Price
$7.23
GF Value